Quotables
"The horse is here to stay, the automobile is only a novelty - fad."
President of Michigan Savings Bank ; 1903
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7214364 | Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections A method and a composition for treatment of pulmonary bacterial infections caused by gram-negative bacteria suitable for treatment of infection caused by Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Pseudomonas aeruginosa, Haemophilus influenzae, ... | 05/08/2007 |
| 6863904 | Compositions and methods for prophylactic and therapeutic supplementation of nutrition in subjects The present invention relates to compositions without added iron and methods for prophylactic nutritional supplementation and therapeutic nutritional supplementation. Specifically, the method involves administering to an individual a composition comprising carotenoi... | 03/08/2005 |
| 6509024 | Composition in the form of water-in-oil emulsion and its cosmetic uses The first embodiment of the present invention provides a composition, which includes: an aqueous phase dispersed in an oily phase; wherein the oily phase includes at least one particle of a crosslinked solid organopolysiloxane elastomer having at least one oxy... | 01/21/2003 |
| 6503883 | Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis The invention relates to a pharmaceutical preparation, which contains an immunosuppressive active agent in dissolved form in a starch capsule, or hard or soft gelatin capsule which has been coated with one or several polymer films. The invention further r... | 01/07/2003 |
| 6235787 | Hydrazine derivatives Hydrazine derivatives of the formula ##STR1## wherein Y is CO or SO2 ; R1 is lower alkyl, lower alkenyl, lower cycloalkyl, lower cycloalkyl-lower alkyl, aryl or aryl-lower alkyl; R2 is lower alkyl, halo-lower alkyl, aryl-l... | 05/22/2001 |
| 6036953 | Heterologous antigens in live cell V. cholerae strains Disclosed is a V. cholerae cell containing a DNA encoding a fusion polypeptide that includes a heterologous antigenic polypeptide sequence such as a portion of C. difficile toxin A. The fusion polypeptide also includes one of the following: (i) an E. coli... | 03/14/2000 |
| 5939397 | Treatment of cholera This invention relates to treatment of cholera and related conditions using oligosaccharide compositions which bind V. cholera toxin and/or one or more serotypes of the organism V. cholera. More specifically, the invention concerns neutralization and remo... | 08/17/1999 |
| 5827534 | Oral dosage composition comprising zonnula occludens toxin and a therapeutic agent for intestinal delivery An oral dosage composition for intestinal delivery of a therapeutic agent comprising: (A) a therapeutic agent selected from the group consisting of a drug compound, a biologically active peptide and a vaccine; and (B) an intestinal absorption enhancing effecti... | 10/27/1998 |
| 5817633 | Treatment of cholera This invention relates to treatment of cholera and related conditions using oligosaccharide compositions which bind V. cholerae toxin and/or one or more serotypes of the organism V. cholerae. More specifically, the invention concerns neutralization and re... | 10/06/1998 |
| 5681862 | Ionene polymers as microbicides A method for controlling the growth of at least one microorganism in an aqueous system susceptible to the growth of said microorganism and in recognized need of said control comprising the step of adding to said aqueous system an ionene polymer in an amou... | 10/28/1997 |
| 5665389 | Oral dosage composition for intestinal delivery and method of treating diabetes An oral dosage composition for intestinal delivery comprising (A) a biologically active ingredient; and (B) zonula occludens toxin, as well as a method for the use of the same.... | 09/09/1997 |
| 5661131 | Treatment of cholera This invention relates to treatment of cholera and related conditions using oligosaccharide compositions which bind V. cholerae toxin and/or one or more serotypes of the organism V. cholerae. More specifically, the invention concerns neutralization and re... | 08/26/1997 |
| 5435996 | Moisturizing compositions containing organosilicon compounds Moisturizing compositions for application to human skin which contain oxyethylene functional organosilanes. When used in skin care applications, these compounds exhibit humectant properties. The oxyethylene functional organosilane is a compound having the... | 07/25/1995 |
| 5344820 | Infection protectant Disclosed herein is an infection protectant which is excellent in infection protective effects and is also safe. .kappa.-Casein, a sialic-acid-conjugated protein derived from cow milk, and a glycomacropeptide derived from .kappa.-casein, each of which is ... | 09/06/1994 |
| 5100647 | Method and formulations for the therapy of cystic fibrosis, Bartter's syndrome and secretory diarrheas, and for diuretic treatment Methods for the therapy of cystic fibrosis, Bartter's syndrome, and secretory diarrheas, and for diuretic treatment, by administering to a patient dodecahydro-7,14-methano-2H,6H-di-pyrido[1,2-a:1',2'-e][1,5]diazocine or a pharmaceutically acceptable ... | 03/31/1992 |
| 4751064 | Synthetic chollera vaccine A synthetic vaccine against cholera and against heat-labile toxin of E. coli comprising a conjugate of a high-molecular weight carrier with a synthetic polypeptide corresponding to part of the sequence of Subunit B of natural cholera toxin. The sequences ... | 06/14/1988 |
| 4251531 | 3,4-Dihydro-quinazoline derivatives 3,4-Dihydro-quinazoline derivatives, such as 6-carboxy-2-(2'-ethoxy-phenyl)-3,4-dihydro-4-oxo-quinazoline, are disclosed. The compounds possess anti-allergy properties and can be used for the treatment of allergic conditions.... | 02/17/1981 |
| 4076815 | Quinoxaline compound and composition, process for preparing compound, and method of combatting cholera therewith Compositions and a method for combatting cholera using novel substituted quinoxalines represented by the formula ##STR1## where R is hydrogen or lower alkyl of 1 to 5 carbon atoms, e.g., methyl to pentyl, are provided. A process for preparing the com... | 02/28/1978 |
